The following research material is made available for information purposes only. It may reflect indications
not yet approved in Canada.
VSL#3® is one of the few probiotic preparations supported by Level One scientific data (double-blind, placebo controlled studies). VSL#3® has been the subject of extensive clinical research in patients with ulcerative colitis, an ileal pouch, irritable bowel syndrome and several other clinical conditions.
Ileal Pouch (Pouchitis) Studies
Review of data supporting VSL#3® for the care of patients with an ileal pouch.
Conditions such as ulcerative colitis, if severe enough, may require that patients have surgery to remove the colon.
Ulcerative Colitis Studies
Ulcerative Colitis (UC) is a disease characterized by inflammation and ulceration of the inner lining of the colon and rectum. Symptoms may include diarrhea, abdominal discomfort, cramping, and an urgent need to have a bowel movement.
The following are some of the original published articles and review papers on VSL#3®.
Going with His Gut Bacteria, Video: Interview with Dr. Fedorak, One on One with Professor Qasim Aziz and Dr. Linden Ruckert.
VSL#3® and The Living Shield are registered trademarks of VSL Pharmaceuticals Inc.
VSL#3® is a probiotic blend that is intended to be used under the supervision of a doctor.
Please consult with your doctor before trying VSL#3®